Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYScientific Reports

Real-world effectiveness of myopia control spectacles and dual-focus contact lenses in the French myopia cohort

6 affiliations
  1. 1Imaging Department, Centre Hospitalier Universitaire de Poitiers
  2. 2Rothschild Foundation Hospital
  3. 3College of Optometry, University of Houston
  4. 4University of New South Wales
  5. 5LabCom CNRS I3M, Université de Poitiers and Centre Hospitalier Universitaire de Poitiers
  6. 6Vision and Eye Research Institute

Abstract

Our study aimed to compare the efficacy of Myopia Control Spectacles (MCS), including Defocus Incorporated Multiple Segment (DIMS) and Highly Aspherical Lenslets (HAL), and dual-focus contact lenses on myopia progression. This longitudinal, real-world study included myopic children aged 7 to 18 years wearing myopia control optical modalities for at least 12 months between 2020 and 2024, with a group using single-vision lenses included for reference. After matching for age, sex, and baseline refractive error, changes in cycloplegic spherical equivalent of the right eye were assessed at twelve, eighteen, and twenty-four months, including a subgroup of children who showed faster initial progression. The cohort included 425 children using dual-focus contact lenses, 307 using DIMS, 118 using HAL, and 850 using single-vision lenses. At twenty-four months, myopia control was not statistically different between the dual-focus contact lenses and myopia control spectacles group. For the subgroup of progressors, the myopia control groups of children showed median progression of − 0.25 to 0.00D. In this European real-world study on different myopia control optical modalities, both MCS and MCL showed no statistical differences in reduction in myopia progression (for 7 to 12 years old, ϵ 2 =0.01 [95%CI = 0 to 0.07]. These findings should be interpreted with caution, as the study relied on spherical equivalent calculated from optical refraction rather than axial length measurement, thereby restricting its ability to fully assess true myopia progression.

Related

  1. Cost-Effectiveness Analysis of Implantable Collamer Lens (ICL) Surgery Versus Contact Lens-Based Correction with Backup Spectacles in Young Adults-A Norwegian Societal Perspective.
    Silvia N W Hertzberg, Ashraf Armia Balamoun, Filippo Confalonieri +4
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Multipoint Defocus Optics Technology Spectacle Lenses for Myopia Control in Children: A One-Year Interim Analysis of a Randomized Trial.
    Yurui Zhang, Xiaotong Han, Ling Jin +4
    Translational vision science & technologyPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  3. Twelve-Month Efficacy and Visual Tolerability of MyoPi Spectacle Lenses in Childhood Myopia : A Randomized Clinical Trial
    Lu Ye, Zhirong Liu, Hui Gao +5
    Ophthalmology sciencePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Effectiveness and Safety of Low-Level Red Light and Short-Wavelength Light Therapy for Myopia Control and Prevention in Children: A Systematic Review
    Saif Hassan Alrasheed, Naveen Kumar Challa
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Cost-effectiveness of monotherapy and combination therapy for myopia control in Chinese children.
    Jinghui Wang, Xuan Li, Meinan He +4
    Journal of global healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{najji2026realworld,
  title = {{Real-world effectiveness of myopia control spectacles and dual-focus contact lenses in the French myopia cohort}},
  author = {Rime Najji and Jost B. Jonas and Mark A. Bullimore and Serge Resnikoff and Alain Bron and Mathieu Naudin and Clément Giraud and Christine Fernandez-Maloigne and Rupert Bourne and Nicolas Leveziel},
  journal = {Scientific Reports},
  year = {2026},
  month = sep,
  doi = {10.1038/s41598-026-71670-4},
  url = {https://doi.org/10.1038/s41598-026-71670-4},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Real-world effectiveness of myopia control spectacles and dual-focus contact lenses in the French myopia cohort
AU  - Rime Najji
AU  - Jost B. Jonas
AU  - Mark A. Bullimore
AU  - Serge Resnikoff
AU  - Alain Bron
AU  - Mathieu Naudin
AU  - Clément Giraud
AU  - Christine Fernandez-Maloigne
AU  - Rupert Bourne
AU  - Nicolas Leveziel
PY  - 2026
DA  - 2026/09/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-71670-4
UR  - https://doi.org/10.1038/s41598-026-71670-4
AB  - Our study aimed to compare the efficacy of Myopia Control Spectacles (MCS), including Defocus Incorporated Multiple Segment (DIMS) and Highly Aspherical Lenslets (HAL), and dual-focus contact lenses on myopia progression. This longitudinal, real-world study included myopic children aged 7 to 18 years wearing myopia control optical modalities for at least 12 months between 2020 and 2024, with a group using single-vision lenses included for reference. After matching for age, sex, and baseline refractive error, changes in cycloplegic spherical equivalent of the right eye were assessed at twelve, eighteen, and twenty-four months, including a subgroup of children who showed faster initial progression. The cohort included 425 children using dual-focus contact lenses, 307 using DIMS, 118 using HAL, and 850 using single-vision lenses. At twenty-four months, myopia control was not statistically different between the dual-focus contact lenses and myopia control spectacles group. For the subgroup of progressors, the myopia control groups of children showed median progression of − 0.25 to 0.00D. In this European real-world study on different myopia control optical modalities, both MCS and MCL showed no statistical differences in reduction in myopia progression (for 7 to 12 years old, ϵ ^2 =0.01 [95%CI = 0 to 0.07]. These findings should be interpreted with caution, as the study relied on spherical equivalent calculated from optical refraction rather than axial length measurement, thereby restricting its ability to fully assess true myopia progression.
SN  - 2045-2322
ER  -